Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

24.56
BATS BZX Real-Time Price
As of 10:40am ET
 -0.39 / -1.56%
Today’s Change
23.85
Today|||52-Week Range
43.63
-42.59%
Year-to-Date
No recent news for Acorda Therapeutics Inc.

Today’s Trading

Previous close24.95
Today’s open24.60
Day’s range24.25 - 24.79
Volume12,118
Average volume (3 months)604,542
Market cap$1.1B
Dividend yield--
Data as of 10:40am ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-40.48%
Earnings growth (this year)-26.48%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+22.71%
P/E ratio79.0
Price/Sales3.79
Price/Book1.78

Competitors

 Today’s
change
Today’s
% change
DERMDermira Inc+0.08+0.24%
SRPTSarepta Therapeutics...+0.03+0.12%
LCILannett Company Inc-0.05-0.16%
ACHNAchillion Pharmaceut...-0.02-0.24%
Data as of 10:43am ET, 07/29/2016

Financials

Last reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.26
Annual revenue (last year)$492.7M
Annual profit (last year)$11.1M
Net profit margin2.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Head-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts

Partner Offers

Search for Jobs